Moreover, stimulation of GLP-1R may widen cerebral arteries, increase blood flow, reduce infarct volume, and ameliorate neurological deficit symptoms produced by ischemic stroke [28], which implies that GLP-1R agonists have neurotrophic and neuroprotective effects in nervous system disease [30]. This evidence concerns the gene GLP1R and nervous system disorder.